“Proposed Class Action Lawsuit alleges Canadian Manufacturer Failed to Warn Patients about Complications of Ozempic”

Published on November 4, 2023, 12:44 am

A proposed class action lawsuit has been filed in B.C. Supreme Court, alleging that the Canadian manufacturer of a drug called Ozempic failed to warn patients about possible complications. While doctors have been prescribing Ozempic for weight loss, Tracy Nygaard had been taking it for its intended purpose – treating Type 2 diabetes. After her first dose, she experienced severe pain, bloating, and vomiting.

Nygaard’s doctor suggested she continue with the once-weekly injections because Ozempic effectively controlled her blood sugar. However, the side effects persisted, and she eventually had to stop taking the drug. Nygaard wishes she had been informed about the potential severe side effects before starting the medication so that she could have made an informed decision.

She has joined a proposed class action lawsuit along with other Canadians who claim they experienced severe complications while taking Ozempic for diabetes or weight loss and were not properly warned about the risk. The lawsuit alleges that the drug maker failed to adequately inform patients about possible gastrointestinal or gall bladder-related issues.

The law firm Siskinds, which specializes in medical class actions, has filed the lawsuit on behalf of these individuals who believe they fall within the class definition. Many of them reported experiencing conditions like stomach paralysis, where food sits in the digestive system causing severe pain.

Dr. Yashar Tashakkor, a North Vancouver physician specializing in obesity, explains that Ozempic slows down the digestive tract to aid weight loss but can cause nausea and vomiting in approximately 10% of users. While he hasn’t seen cases of stomach paralysis among his patients, he will now discuss its possibility when prescribing Ozempic.

In response to these allegations and claims made in the proposed class action lawsuit, Novo Nordisk (the Canadian manufacturer of Ozempic) issued a statement stating their confidence in the safety and efficacy of their GLP-1 medicines when used as directed by healthcare professionals.

It’s important to note that none of the claims in the proposed class action lawsuit have been tested in court. A judge will ultimately decide whether the lawsuit will proceed and if affected individuals like Tracy Nygaard can seek relief.

As the story develops, it highlights the need for pharmaceutical companies to provide thorough and comprehensive information about potential side effects associated with their products, enabling patients to make informed decisions about their health. It also emphasizes the importance for healthcare professionals to discuss all risks and benefits with their patients before prescribing any medication.

If you or someone you know has experienced severe complications while taking Ozempic or any other medication, it is crucial to consult with a healthcare professional and explore your legal options.